Search Results
Baxter Provides Update on North Cove, N.C., Facility and Hurricane Helene Relief Plans for Community
Baxter International Inc. (NYSE:BAX), a global medtech leader, today shared updates regarding the impact of Hurricane Helene, which brought unprecedented rain and extensive flooding to Western North Carolina, on the operations of its North Cove facility in Marion, N.C.
Baxter Launches Next Generation of THE VEST for Airway Clearance
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today unveiled its next generation airway clearance system, The Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System supports daily therapy for adults and children with certain chronic lung conditions and retained secretions.
Baxter Appoints Jeffrey A. Craig to Its Board
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Jeffrey (Jay) A. Craig, former executive chair and chief executive officer (CEO) of Meritor Corporation, to its board of directors. Mr. Craig will serve on Baxter’s Audit Committee. His appointment is effective today and brings the total number of directors serving the company to 12.
Baxter to Present at 2024 Wells Fargo Healthcare Conference
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:30 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Tuesday, March 4, 2025.
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ:CG) today announced that they have signed a definitive agreement under which Carlyle is to acquire Baxter's Kidney Care segment, to be named Vantive, for $3.8 billion.
Baxter Reports Second-Quarter 2024 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2024.
Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium in 0.9% Sodium Chloride Injection Due to Potential for Elevated Endotoxin Levels
Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of Heparin Sodium in 0.9% Sodium Chloride Injection to the consumer level due to the potential for elevated endotoxin levels based on issues related to the bacterial endotoxin test specific to lot number N008235.
Taking Charge of Her Career
Kori Caya has worn multiple hats during her more than 20 years at Baxter – and she’s worn them all well.
Global IT Outage
July 21, 2024, 1 pm CT: Baxter has made significant progress restoring the areas within our operations that were impacted by the IT outage that is affecting hospitals, industries, companies and countries around the world. Our top priority is supporting patient care needs while maintaining the quality, security and supply continuity of our products. At this time:
Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results on Tuesday, August 6, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I898552708 to pre-register for the call and receive the call information.